NJU Clinical Research - Providing hope through innovation.

Clinical Research Programs

NJU physicians are engaged in a variety of clinical research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases. We are proud of the leadership role our doctors take in helping to prove the safety and efficacy of new treatments, and the opportunity it gives us to make those options available to our patients. Those potential advantages, however, are always considered in the context of the overall health and well-being of our patients.

Our clinical research department has a dedicated research staff who will assist you through your entire journey. Our state-of-the-art facilities offer a locked storage area for all trial-specific documentation and Investigational Product (IP), -70°F freezers to store specimens and IP, electrocardiogram (ECG) machines, refrigerated centrifuges for precise temperature management and sample protection, and pharmacokinetics (PK) capabilities.

If you think you may be eligible for and interested in participating in a clinical research program, your NJU urologist will discuss the potential benefits and risks with you so that you and your family can make an informed decision.


New Jersey Urology (NJU) physicians are engaged in a variety of research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases.

NJU’s Senior Vice President of Clinical Research, Derek Grimes, is interviewed by UroGPO to discuss what makes clinical research a success in the field of urology.


New Jersey Urology has extensive experience in conducting Phase 1b – IV trials in the following urological therapeutic areas:

  • Bladder cancer
  • BPH (Benign Prostatic Hyperplasia)
  • Erectile dysfunction/impotence
  • High Grade PIN
  • Hypogonadism
  • Neurogenic bladder
  • Overactive bladder
  • Premature ejaculation
  • Prostate cancer
  • Prostate cancer prevention
  • Prostatitis
  • Urinary incontinence
  • Urinary tract infection treatment


Prostate Cancer Immunotherapies

You may be eligible for New Jersey Urology’s immunotherapy clinical trials now available at our Saddle Brook and West Orange, New Jersey Cancer Treatment Centers.

What is Immunotherapy?
Immunotherapy teaches your body to spot and destroy cancer cells, and may help your immune system long after your treatment ends.

Types of Immunotherapy
Certain types of immunotherapy attack cancer while sparing healthy cells or slow its spread to other parts of the body.

Register now to see if you qualify or call 973-846-7028.

Sponsor / Study Title:

MANA RBM / ESCALATE, A Phase III Randomized Study Comparing Enzalutamide or Darolutamide with Radium-223 vs Enzalutamide or Darolutamide with Placebo and the Effect upon Symptomatic Skeletal Event-Free Survival for mCRPC Patients

Protocol Number:

Principal Investigator:
(Study Doctor)




Domenico Savatta, MD, FACS



New Jersey Urology
1515 Broad Street, Suite 120
Bloomfield, NJ 07003

You may be eligible for a Phase 3 Prostate Cancer Clinical Trial for metastatic castration-resistant prostate cancer (mCRPC) that may help to stop or prevent the cancer from spreading to your bones. For more information, call us at 908.484.6575.

ClinicalTrials.gov – Study: NCT04237584

You are invited to take part in a research study. This research study is studying Xtandi (enzalutamide) or Nubeqa (darolutamide) followed by Xofigo (radium-223) or Placebo (saltwater) as a possible treatment for metastatic castration-resistant prostate cancer (mCRPC). MANA RBM is sponsoring this research study. The Informed Consent provides a summary of this research. It describes the important information that we believe most people need in order to decide whether to take part in this research.

Sponsor / Study Title:

Urovant Sciences GmbH / Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Protocol Number:

Principal Investigator:
(Study Doctor)




Eric J. Margolis, MD


(833) 876-8268

New Jersey Urology
1515 Broad Street, Suite 120
Bloomfield, NJ 07003

Courage Study for men on BPH therapy experiencing OAB symptoms

About the COURAGE Study

A clinical research study is testing the safety and effectiveness of an investigational drug in men on BPH therapy experiencing OAB symptoms. The investigational drug, vibegron, is compared with a placebo. A placebo looks exactly like the investigational drug but contains no active medication. Over 1000 participants in approximately 135 study centers across North America and Europe are expected to take part in the COURAGE Study.

ClinicalTrials.gov – Study: NCT03902080 or Enroll Here.


To make an appointment with an NJU physician with expertise in Clinical Research, please call one of the phone numbers listed below.


1515 Broad Street
Suite 120
Bloomfield, NJ 07003
Phone: (973) 873-7000

Cherry Hill

2090 Springdale Road
Suite B
Cherry Hill, NJ 08003
Phone: (856) 751-9010


570 South Avenue East
Building A
Cranford, NJ 07106
Phone: (908) 603-4201


3311 Brunswick Pike
Lawrenceville, NJ 08648
P: 609.716.7030
Phone: (609) 716-7030

Saddle Brook

160 Pehle Avenue
Suite 103
Saddle Brook, NJ 07663
Phone: (201) 881-1000

West Orange

375 Mount Pleasant Avenue
Suite 251
West Orange, NJ 07052
Phone: (973) 323-1300

Mount Laurel

15000 Midlantic Drive, Suite 100
Mount Laurel, NJ 08054
Phone: (856) 840-4563


2401 Evesham Road, Suite F
Voorhees, NJ 08043
Phone: (856) 673-1613

Why Choose NJU?

At New Jersey Urology (NJU), our team of experienced urologists and clinical support professionals are dedicated to improving the health of our patients. As one of the country’s most prominent urology groups, we specialize in all areas of urological health and offer comprehensive treatment options, in-house laboratory testing and six state-of-the-art cancer treatment centers.

Discover the NJU difference today. Contact us and our administrative team will respond back to you as soon as possible.